Judy Hemberger | PhD MBA – CEO
Dr. Hemberger has more than thirty years of experience in the pharmaceutical industry. She was co-founder and COO of Pharmion Corporation prior to its sale to Celgene for $2.9 billion. Dr. Hemberger’s expertise includes clinical development, global regulatory and early commercialization of pharmaceutical products. She is a demonstrated leader of both domestic and international operations. Dr. Hemberger is highly effective at raising capital for start-up ventures, including private equity, initial public offerings, and secondary placements. She is a board member of a wide variety of health care companies, public and private, and has served as a consultant and partner in venture capital firms. In addition to her tenure at Pharmion, Dr. Hemberger has served as CEO of Zosano (formerly Macroflux) and as a Venture Partner for Nomura Phase 4 Ventures. She has served as a director on over 16 health care boards of directors. Dr. Hemberger is a graduate of Mt. St. Scholastic College (BS), University of Missouri (PhD), and Business Rockhurst College (MBA).
Tin Tin Su | PhD – CSO and Co-Founder
Dr. Su has more than twenty years’ experience in radiation biology and genetics. A full professor at the University of Colorado at Boulder and head of the Su Lab, Dr. Su has a proven track record in securing external funds from Federal, State, and non-profit organizations. Dr. Su co-founded SuviCa. She also devised and patented a whole-animal screening technology to quickly and efficiently identify potential drug candidates. Dr. Su is an expert in radiation biology and genetic models of cancer. A current member of the editorial board for Current Biology, Dr. Su has authored more than fifty scientific papers. Dr. Su is a graduate of Mt. Holyoke College (BA) and Carnegie-Mellon University (PhD) and did post-doctoral work at the University of California, San Francisco.
Wendi Petro | MBA – CFO
Wendi Petro has twenty years’ experience working with small and mid-sized companies in accounting, accounts receivable, and as CFO, specifically in academic research and biotech startups. Mrs. Petro is a graduate of CU Denver, MBA (Finance), MS (Management & Organization).